Atypical hemolytic uremic syndrome - Wikidata - awgldk - TriplyDB

Atypical hemolytic uremic syndrome

Atypical hemolytic uremic syndrome

http://www.wikidata.org/entity/Q21202864

about

Recessive mutations in DGKE cause atypical hemolytic-uremic syndrome Clinical Practice Guidelines for the Management of Atypical Hemolytic Uremic Syndrome in Korea Advances and challenges in the management of complement-mediated thrombotic microangiopathies Hemolytic uremic syndrome The complement system and adverse pregnancy outcomes Current treatment of atypical hemolytic uremic syndrome Hemolytic uremic syndrome: toxins, vessels, and inflammation Complement regulator CD46: genetic variants and disease associations Eculizumab: a review of its use in atypical haemolytic uraemic syndrome Haemolytic uraemic syndrome.Guidelines on the Use of Therapeutic Apheresis in Clinical Practice-Evidence-Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue.Partial ADAMTS13 deficiency in atypical hemolytic uremic syndrome.Epidemiology of haemolytic uremic syndrome in children. Data from the North Italian HUS network.Exploiting the nephrotoxic effects of venom from the sea anemone, Phyllodiscus semoni, to create a hemolytic uremic syndrome model in the rat Long-term eculizumab improves clinical outcomes in atypical hemolytic uremic syndrome.Neonatal onset atypical hemolytic uremic syndrome successfully treated with eculizumab.Neonatal hemolytic uremic syndrome after mother-to-child transmission of a low-pathogenic stx2b harboring shiga toxin-producing Escherichia coli.Autoimmunity: homeostasis of innate immunity gone awry.Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects.Neurologic involvement in atypical hemolytic uremic syndrome and successful treatment with eculizumab.Atypical HUS: time to take stock of current guidelines and outcome measures?Complement disorders and hemolytic uremic syndrome.Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS).Eculizumab therapy for atypical haemolytic uraemic syndrome due to a gain-of-function mutation of complement factor B.A complementary component to atypical haemolytic uraemic syndrome.Complement therapy in atypical haemolytic uraemic syndrome (aHUS).Early infantile onset of atypical hemolytic-uremic syndrome is caused by recessive mutations in DGKE.A novel hybrid CFHR1/CFH gene causes atypical hemolytic uremic syndrome Rapid recovery of membrane cofactor protein (MCP; CD46) associated atypical haemolytic uraemic syndrome with plasma exchange.Comprehensive genetic analysis of complement and coagulation genes in atypical hemolytic uremic syndrome.Post-transplant recurrence of atypical hemolytic uremic syndrome in a patient with thrombomodulin mutation.Diagnostic criteria for atypical hemolytic uremic syndrome proposed by the Joint Committee of the Japanese Society of Nephrology and the Japan Pediatric Society.Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.Macrovascular involvement in a child with atypical hemolytic uremic syndrome.Haemolytic uremic syndrome following fire ant bites Phenotypic expansion of DGKE-associated diseases Acute Progression of Adult-Onset Atypical Hemolytic-Uremic Syndrome due to CFH Mutation: A Case Report.A case of atypical hemolytic uremic syndrome successfully treated with eculizumab.

P2860

Q24337607-C3D55104-4DF6-4956-9685-9225D351267C Q26739894-47ABFF68-5896-4667-BFAF-90096C10EE46 Q26796453-D4BFC583-923A-4F36-92BC-D6BD35EB137A Q26799054-E6F3B3A7-BE34-4741-9CB9-3CEF2C5C13B9 Q26863600-720C8BCC-BCF8-437C-94E7-1B08F829E0D5 Q27003211-D2D33AA7-9816-4406-BE4E-F6D2B6F0BF11 Q28083347-8EF42F3E-4AA9-42EF-8369-28F23E2AA41B Q28263110-E8A665DF-CCDD-4B91-A5F8-7B393A64C4ED Q28302228-19AA3D45-B471-491E-82A2-C1296E5F31E0 Q30244707-D7850D0F-EA20-4764-ABEF-74A97B1BC1A5 Q30276550-26ED0457-8125-4C51-8DB4-F39DC8BCDE52 Q30543370-EEB0064B-2E18-4CB7-A9A0-C6057AB542D7 Q31010561-BF625B9F-25A7-43B2-9B62-D44E9EB7602E Q33402623-16E65A92-183E-44F7-8C4D-5060386CA5E5 Q33402795-8B363847-68CF-40B9-BC3F-AF328891FBD3 Q33403172-D9D25E16-78A1-43AB-8CB0-CB98CD3E9CE3 Q33403700-C5E42C62-3063-437E-851C-0B436A30DBC8 Q33403747-E2D18A47-C5DE-4796-8C3C-5C257CC69F33 Q33404640-E85E4CFC-3FD5-447C-BA26-739BD7B2F04A Q33404847-DA8A710E-952B-42C4-BAA0-33E020D204CE Q33404888-96EFA947-0C21-464C-9E8A-4717E0782335 Q33405726-3738630C-C6BC-4FB1-822E-FE3075D376B4 Q33405728-0840A5BF-83AF-4574-B661-07D912CD87E1 Q33405802-34F404E9-AC69-423D-8A5F-4D4C2D9A3A8C Q33406356-97438C26-0548-4B6C-8733-E9E5452B6F4E Q33407344-96E12BD1-4A04-4042-90C6-C2DA8D7B65E1 Q33408476-AAC176B7-A46D-4184-A859-59A16BF05318 Q33408733-96A8E27A-5B5A-406D-AB86-4C0ABA1D44F6 Q33409272-D4A3BD8C-11CA-4161-88B5-CE4D204BA1CC Q33409307-B2B99830-CDC4-4ABD-906A-092088B94CF9 Q33410165-3E33CFA1-E202-49F2-8627-A37F33CE0313 Q33410276-CE278478-709D-498E-BA4A-BCFC2E5DF918 Q33410871-759F0761-B154-4515-9984-13C5652AFAF6 Q33412143-A8B2D72C-BCF9-4C1E-9366-B11AE0F650F7 Q33412152-B19E5AE0-2DA2-4D61-8690-CFDF1D8F2331 Q33412191-4BE5349F-661E-4F60-BEDF-232E9A38E992 Q33412539-C77E15DC-E5A9-4BE7-AA1A-EBC941707CA5 Q33413254-0051A5AB-EDC5-4EA6-A4B0-F97AA44D50FE Q33413460-298108BD-103E-4CC3-B96E-6682F5813DB0 Q33413510-7A7F1DAB-4FA6-425F-9B55-1850E25A212C

P2860

Atypical hemolytic uremic syndrome

http://www.wikidata.org/entity/Q21202864

description

2011 nî lūn-bûn

@nan

2011 թուականին հրատարակուած գիտական յօդուած

@hyw

2011 թվականին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

name

Atypical hemolytic uremic syndrome

@ast

Atypical hemolytic uremic syndrome

@en

Atypical hemolytic uremic syndrome

@en-gb

Atypical hemolytic uremic syndrome

@nl

type

label

Atypical hemolytic uremic syndrome

@ast

Atypical hemolytic uremic syndrome

@en

Atypical hemolytic uremic syndrome

@en-gb

Atypical hemolytic uremic syndrome

@nl

prefLabel

Atypical hemolytic uremic syndrome

@ast

Atypical hemolytic uremic syndrome

@en

Atypical hemolytic uremic syndrome

@en-gb

Atypical hemolytic uremic syndrome

@nl

P1433

Q21202864-48FE7B2A-EE05-4B9C-AD63-681B5A49515F

P1476

Q21202864-5229E961-EEB4-43D2-A87A-14345AB41EF1

P2860

Q21202864-012805E6-BB0D-4A0B-A264-48B740392E8E

Q21202864-07455D34-4728-4BA6-8A45-CD655993EA19

Q21202864-0770F1AA-0D04-4389-B7D3-5EFBEB9CF180

Q21202864-09FD8A8C-2A38-40F5-AE8D-833EA5E8FF08

Q21202864-0A502B4B-8DD5-4583-91CE-6F2595F36FEA

Q21202864-0B365D74-6B5F-4C65-A1D7-25A780240A40

Q21202864-0E39D452-E8F7-4B7A-B6C8-28B1F770EFF1

Q21202864-0EA79F9C-8E7B-44EC-9B5F-0A4A771FC1AE

Q21202864-15161150-EA2E-4067-A3C0-48DA4AC0BD96

Q21202864-167B5F27-5000-4A5F-962F-E498F3609C5A

P2888

Q21202864-2D0CB222-1C7D-470D-A252-23178A70155F

P304

Q21202864-FFA3A0BA-F6DD-4393-BD19-1740D75BA92D

P31

Q21202864-D2860A3A-D7DC-4DAC-901E-4BCCEE504C07

P3181

Q21202864-7625C086-C5E3-43D1-9E70-7795ECA66A0A

P356

Q21202864-18F855D9-7705-4EA5-9FD5-94C3E639AAF7

P407

Q21202864-91F13141-7D57-47D6-BD4D-0A608E6CDC75

P433

Q21202864-DD3121F4-5AB3-43B5-944B-20AF62DF3952

P478

Q21202864-C3C0A1C8-D2FB-47F3-9581-C6C4BB0DCF3B

P50

Q21202864-E80B382B-C4F0-4D05-BE55-E48D94A37EBF

Q21202864-E905C373-46EB-4FFD-A6E3-20307C210522

P577

Q21202864-4E0F0CC1-B6B2-4CF3-A492-5400BB4B6834

Q21202864-E53D081A-6E0C-45F7-A76C-6A6E7F7D15B0

P5875

Q21202864-1FAAB6A2-4F82-448A-933D-DD20C08E161C

P6179

Q21202864-7CF518D6-9325-4E4A-9127-1D8A271AA7D8

P698

Q21202864-3B773968-3DD7-4E03-9626-250535F7A0E9

P932

Q21202864-CE2743B1-2E67-4075-8EBD-9331F3357649

P3181

P356

P1433

Orphanet Journal of Rare Diseases

P1476

Atypical hemolytic uremic syndrome

@en

P2860

Deletion of complement factor H-related genes CFHR1 and CFHR3 is associated with atypical hemolytic uremic syndrome

Recurrent atypical hemolytic uremic syndrome associated with factor I mutation in a living related renal transplant recipient

Structural basis for engagement by complement factor H of C3b on a self surface

Eculizumab safely reverses neurologic impairment and eliminates need for dialysis in severe atypical hemolytic uremic syndrome

Clinical features of anti-factor H autoantibody-associated hemolytic uremic syndrome

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

VEGF inhibition and renal thrombotic microangiopathy

Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome

P2888

P304

60

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1570802

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1750-1172-6-60

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Véronique Frémeaux-Bacchi

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2011-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51628633

http://www.w3.org/2001/XMLSchema#string

P6179

1021959275

http://www.w3.org/2001/XMLSchema#string

P698

21902819

http://www.w3.org/2001/XMLSchema#string

P932

3198674

http://www.w3.org/2001/XMLSchema#string